Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

AZ’s Imfinzi combo bombs again in non-small cell lung cancer

AZ’s Imfinzi combo bombs again in non-small cell lung cancer

The readout will also be a concern to Bristol-Myers Squibb, which is relying on TMB data to make a case for its PD-1 inhibitor Opdivo (nivolumab) after the drug ... BMS is testing the FDA’s view on this with an application for Opdivo plus its CTLA4

Opdivo trial overshadows BMS financial results

Opdivo trial overshadows BMS financial results line setting, and BMS suggested the chemo group “overperformed” while Opdivo’s activity was as expected. ... We continue to expect growth for Opdivo in the US and ex-US this year compared to last year,” he added.

New products help lift Roche outlook despite biosimilar onslaught

New products help lift Roche outlook despite biosimilar onslaught and BMS' Opdivo.

Celgene cuts back Jounce alliance ahead of BMS merger

Celgene cuts back Jounce alliance ahead of BMS merger BMS has its own anti-ICOS agonist, BMS-986226, in clinical trials and the approved PD-1 inhibitor Opdivo, making it logical for Celgene to hand back rights to vopratelimab and

Hal Barron touts new drive to improve GSK’s research output

Hal Barron touts new drive to improve GSK’s research output GSK won’t be able to catch up with immunotherapy leaders, such as Merck &Co’s Keytruda and BMS’ Opdivo, but Dr Barron still sees opportunities in developing the next generation

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics